Sign in

CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company

Annexon, Inc.

Sign in to watch
Ticker
ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
275414423
Phone
(650) 822-5500
Business address
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. 4 Open-market buy PRESIDENT AND CEO bought 26,065 shares at $3.83 ($99,829)
  5. 144 Insider Sale of Securities
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations · Other events
  10. 8-K Event Executive or director change · Regulation FD disclosure
  11. SCHEDULE 13G Stake Statement of Beneficial Ownership
  12. 8-K Event Other events
  13. 8-K Event Material agreement · New debt or obligation · Other events
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 1 of 27 · 524 filings